A Non-interventional Multi-country Cohort Study to Assess the Safety of EVUSHELD™ During Pregnancy

Trial Identifier:	D8850R00006
Sponsor:	AstraZeneca
Collaborator:	AETION
NCTID::	NCT05847140
Start Date:	June 2022
Primary Completion Date:	January 2024
Study Completion Date:	January 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.